Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

The role of antiplatelet therapy as primary prophylaxis of thrombosis in low-risk essential thrombocythemia has not been studied in randomized clinical trials. We assessed the benefit/risk of low-dose aspirin in 433 patients with low-risk essential thrombocythemia (271 with a CALR mutation, 162 with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Alvarez-Larrán, Alberto, Pereira, Arturo, Guglielmelli, Paola, Hernández-Boluda, Juan Carlos, Arellano-Rodrigo, Eduardo, Ferrer-Marín, Francisca, Samah, Alimam, Griesshammer, Martin, Kerguelen, Ana, Andreasson, Bjorn, Burgaleta, Carmen, Schwarz, Jiri, García-Gutiérrez, Valentín, Ayala, Rosa, Barba, Pere, Gómez-Casares, María Teresa, Paoli, Chiara, Drexler, Beatrice, Zweegman, Sonja, McMullin, Mary F., Samuelsson, Jan, Harrison, Claire, Cervantes, Francisco, Vannucchi, Alessandro M., Besses, Carlos
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967571/
https://ncbi.nlm.nih.gov/pubmed/27175028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.146654
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados